AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report - AstraZeneca (NASDAQ:AZN), GSK (NYSE:GSK)
Western pharmaceutical companies and investors are driving a record number of licensing deals with Chinese drugmakers.